Image Strip

TransIT-siQUEST® Transfection Reagent

A high efficiency, low toxicity, siRNA transfection reagent for mammalian cells

Product No.QuantityPriceAdd to
MIR 21140.4 ml$221.00
MIR 21101 ml$356.00
MIR 21155 x 1 ml$1,589.00
MIR 211610 x 1 ml$3,000.00
To inquire about bulk pricing, please call 888-530-0801.
International inquiries please call +1-608-441-2852.
 

Resources

Protocol
MSDS
Technical Report
FAQs
Citations
Contact Technical Support
Related Products

View Data

  • Broad Spectrum siRNA Delivery—Utilize one transfection reagent and protocol for a wide variety of cells.
  • Low Cellular Toxicity—Maintain cell density and reduce experimental biases.
  • Reproducible Results—Obtain consistent, targeted gene knockdowns from day to day.
  • High Knockdown Efficiency—Achieve optimal gene silencing in a large percentage of cells to ensure experimental success.

Cell Types Successfully Transfected by Mirus Bio:
A549, BHK-21, BNL CL.2, C2C12, CHO-K1, COS-7, HEK 293, HeLa, Hepa1c1c7, HepG2, MCF-7, NIH 3T3, Primary Mouse Hepatocytes, RAW 264.7, and Vero cells.

Data

Figure 1: Inhibition of PPAR-alpha Expression in Primary Mouse Hepatocytes Using the TransIT-siQUEST® Reagent.
Figure 2: Inhibition of Stably Expressed Firefly Luciferase Using the TransIT-siQUEST® Reagent.
Figure 3: Efficient Target Gene Knockdown in Selected Cell Lines Using TransIT-siQUEST® Reagent.
Figure 4: Visualization of Fluorescently-Labeled siRNA Transfected with the TransIT-siQUEST® Reagent.

Figure 1
 
Figure 1. Inhibition of PPAR-alpha Expression in Primary Mouse Hepatocytes Using the TransIT-siQUEST® Reagent. Primary mouse hepatocytes were transfected with an anti-PPAR-alpha siRNA or a non-targeting control siRNA using the TransIT-siQUEST® Reagent. Twenty-four hours post-transfection, the amount of PPAR-alpha mRNA was measured relative to GAPDH mRNA levels using qRT-PCR and then scaled to the expression level of the specific target mRNA in the Opti-MEM® media only (untreated) control.
Figure 2
 
Figure 2. Inhibition of Stably Expressed Firefly Luciferase Using the TransIT-siQUEST® Reagent. Cell lines stably expressing firefly luciferase were transfected with an anti-firefly luciferase siRNA or a reagent alone control using the TransIT-siQUEST® Reagent. Twenty-four hours post-transfection, luciferase expression was measured and compared to the reagent alone control.
Figure 3
 
Figure 3. Efficient Target Gene Knockdown in Selected Cell Lines Using TransIT-siQUEST® Reagent. Reporter plasmids expressing both firefly and sea pansy luciferase were co-transfected into the indicated cell lines using TransIT® Plasmid Transfection Reagents. Targeted knockdown was achieved by transfection of an anti-firefly luciferase siRNA using the TransIT-siQUEST® Reagent. Twenty-four hours later, firefly luciferase expression was normalized to sea pansy luciferase expression and compared to the reagent alone control.
Figure 4 - Panel 1 Figure 4 - Panel 2
A B
 
Figure 4. Visualization of Fluorescently-Labeled siRNA Transfected with the TransIT-siQUEST® Reagent. (A) HeLa cells were transfected with a Cy™3-labeled siRNA using the TransIT-siQUEST® Reagent or (B) a reagent alone control. At 4 hours post-transfection, the cells were fixed, counterstained, and analyzed by confocal microscopy to visualize the siRNA (red), nuclei (blue), and actin (green).

Home | Contact Us | Site Map | Terms and Conditions | Patents and Trademarks | Privacy Policy
© 2008 Mirus Bio Corporation. All Rights Reserved.